EXAS
Income statement / Annual
Last year (2024), Exact Sciences Corporation's total revenue was $2.76 B,
an increase of 10.37% from the previous year.
In 2024, Exact Sciences Corporation's net income was -$1.03 B.
See Exact Sciences Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$2.76 B |
$2.50 B |
$2.08 B |
$1.77 B |
$1.49 B |
$876.29 M |
$454.46 M |
$265.99 M |
$99.38 M |
$39.44 M |
| Cost of Revenue |
$840.15 M
|
$654.25 M
|
$574.39 M
|
$458.76 M
|
$354.32 M
|
$216.72 M
|
$117.98 M
|
$79.20 M
|
$45.20 M
|
$24.50 M
|
| Gross Profit |
$1.92 B
|
$1.85 B
|
$1.51 B
|
$1.31 B
|
$1.14 B
|
$659.58 M
|
$336.48 M
|
$186.79 M
|
$54.18 M
|
$14.94 M
|
| Gross Profit Ratio |
0.7
|
0.74
|
0.72
|
0.74
|
0.76
|
0.75
|
0.74
|
0.7
|
0.55
|
0.38
|
| Research and Development Expenses |
$431.21 M
|
$425.88 M
|
$393.42 M
|
$385.65 M
|
$554.05 M
|
$139.69 M
|
$68.21 M
|
$42.14 M
|
$33.47 M
|
$33.91 M
|
| General & Administrative Expenses |
$781.83 M
|
$1.42 B
|
$737.30 M
|
$801.26 M
|
$481.72 M
|
$352.45 M
|
$178.29 M
|
$109.04 M
|
$76.90 M
|
$57.95 M
|
| Selling & Marketing Expenses |
$894.13 M
|
$203.90 M
|
$846.01 M
|
$861.89 M
|
$589.92 M
|
$385.18 M
|
$249.45 M
|
$153.92 M
|
$112.83 M
|
$82.14 M
|
| Selling, General & Administrative Expenses |
$1.68 B
|
$1.62 B
|
$1.58 B
|
$1.66 B
|
$1.07 B
|
$737.63 M
|
$427.74 M
|
$262.96 M
|
$189.72 M
|
$140.09 M
|
| Other Expenses |
$868.06 M
|
-$3.69 M
|
$110.69 M
|
$95.00 M
|
$69.73 M
|
$16.04 M
|
$0.00
|
$107.60 M
|
$0.00
|
$4.10 M
|
| Operating Expenses |
$2.97 B
|
$2.06 B
|
$2.09 B
|
$2.14 B
|
$1.70 B
|
$893.36 M
|
$495.95 M
|
$305.10 M
|
$223.20 M
|
$174.00 M
|
| Cost And Expenses |
$3.81 B
|
$2.71 B
|
$2.66 B
|
$2.60 B
|
$2.05 B
|
$1.11 B
|
$613.93 M
|
$384.30 M
|
$268.39 M
|
$198.51 M
|
| Interest Income |
-$5.30 M
|
-$5.35 M
|
$19.63 M
|
$1.79 M
|
$6.57 M
|
$23.77 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$31.97 M
|
$24.42 M
|
$19.63 M
|
$18.61 M
|
$95.98 M
|
$61.60 M
|
$36.79 M
|
$206,000.00
|
$213,000.00
|
$6,000.00
|
| Depreciation & Amortization |
$214.86 M
|
$206.61 M
|
$226.20 M
|
$206.17 M
|
$179.08 M
|
$55.67 M
|
$23.08 M
|
$15.56 M
|
$11.51 M
|
$7.75 M
|
| EBITDA |
-$789.33 M |
$41.88 M |
-$386.74 M |
-$617.73 M |
-$632.86 M |
-$217.75 M |
-$115.18 M |
-$98.82 M |
-$155.49 M |
-$150.05 M |
| EBITDA Ratio |
-0.29
|
0.02
|
-0.23
|
-0.42
|
-0.31
|
-0.25
|
-0.35
|
-0.44
|
-1.7
|
-4.03
|
| Operating Income Ratio |
-0.38
|
-0.09
|
-0.28
|
-0.47
|
-0.37
|
-0.27
|
-0.35
|
-0.44
|
-1.7
|
-4.03
|
| Total Other Income/Expenses Net |
$27.15 M
|
$13.27 M
|
-$39.06 M
|
$13.17 M
|
-$61.37 M
|
-$35.07 M
|
-$15.59 M
|
$3.73 M
|
$1.81 M
|
$1.27 M
|
| Income Before Tax |
-$1.02 B
|
-$201.75 M
|
-$632.57 M
|
-$842.51 M
|
-$857.11 M
|
-$268.85 M
|
-$175.06 M
|
-$114.58 M
|
-$167.21 M
|
-$157.80 M
|
| Income Before Tax Ratio |
-0.37
|
-0.08
|
-0.3
|
-0.48
|
-0.57
|
-0.31
|
-0.39
|
-0.43
|
-1.68
|
-4
|
| Income Tax Expense |
$7.30 M
|
$2.40 M
|
-$9.06 M
|
-$246.88 M
|
-$8.57 M
|
-$184.86 M
|
$92,000.00
|
-$187,000.00
|
-$11.30 M
|
-$7.74 M
|
| Net Income |
-$1.03 B
|
-$204.15 M
|
-$623.51 M
|
-$595.63 M
|
-$848.53 M
|
-$83.99 M
|
-$175.15 M
|
-$114.40 M
|
-$167.21 M
|
-$157.80 M
|
| Net Income Ratio |
-0.37
|
-0.08
|
-0.3
|
-0.34
|
-0.57
|
-0.1
|
-0.39
|
-0.43
|
-1.68
|
-4
|
| EPS |
-5.59 |
-1.13 |
-3.54 |
-3.48 |
-5.61 |
-0.64 |
-1.43 |
-0.99 |
-1.63 |
-1.71 |
| EPS Diluted |
-5.59 |
-1.13 |
-3.54 |
-3.48 |
-5.61 |
-0.64 |
-1.43 |
-0.99 |
-1.63 |
-1.71 |
| Weighted Average Shares Out |
$184.20 M
|
$180.14 M
|
$176.35 M
|
$171.35 M
|
$151.14 M
|
$131.26 M
|
$122.21 M
|
$115.68 M
|
$102.34 M
|
$92.14 M
|
| Weighted Average Shares Out Diluted |
$184.20 M
|
$180.14 M
|
$176.35 M
|
$171.35 M
|
$151.14 M
|
$131.26 M
|
$122.21 M
|
$115.68 M
|
$102.34 M
|
$92.14 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
